Eugia Pharma Specialities Limited

Eugia Pharma Specialities Limited - pharma in Ameerpet, Telangana, India. FY 2026 financials and compliance.
CIN U24297TG2013PLC087048 Incorporated 17 April 2013 ROC Hyderabad HQ Ameerpet, Telangana, India
Active Public Limited Company pharma
Data last updated
Revenue · FY 2025
₹4,828.71 Cr
▲ 12.00% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹800 Cr
Registered with MCA
Paid-up capital
₹621.01 Cr
Issued & subscribed
Open charges
None
Satisfied ₹724 Cr
Company age
13 yrs
Est. 2013
Employees · EPFO
2,763
Latest available

About Eugia Pharma Specialities Limited

Data last updated: 06 January 2026

Eugia Pharma Specialities Limited is a public limited company based in Ameerpet, Telangana, India, a subsidiary of Aurobindo Pharma Ltd. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 17 April 2013, the company has been in operation for over 13 years.

Registered with ROC Hyderabad under CIN U24297TG2013PLC087048.

Capital: an authorised share capital of ₹800 Cr and a paid-up capital of ₹621.01 Cr. It is led by directors including Madan Mohan Reddy Mettu and Veerayya Chowdary Kosaraju.

Last AGM: 08 September 2025. Financial statements filed for year ended 31 March 2025. Office: Plot No.2 Maitrivihar, Ameerpet, Telangana, India – 500038.

As per the financials filed for FY 2025, the company reported a revenue of ₹4,828.71 Cr, a growth of 12% compared to the previous year.

The company has a workforce of approximately 2,763 employees as per the latest available data. It operates as a subsidiary of Aurobindo Pharma Ltd. Its group structure includes 2 subsidiaries.

As per MCA filings, the company has satisfied charges of ₹724 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website eugiapharma.com.

Company Details of Eugia Pharma Specialities Limited
CIN U24297TG2013PLC087048
Registration Number 087048
Incorporation Date 17 April 2013
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 08 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Aurobindo Pharma Ltd
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
  • Social Media
  • Registered Address
    Plot No.2 Maitrivihar, Ameerpet, Telangana, India – 500038
  • Industry
    Pharma, Drug Formulation & Development
Company report
Eugia Pharma Specialities Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Eugia Pharma Specialities Limited report

Financials, compliance, directors, charges, ownership and filings for Eugia Pharma Specialities Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Eugia Pharma Specialities Limited

Eugia Pharma Specialities Limited has one previous CIN (Corporate Identification Number): U24297AP2013PLC087048. The current CIN is U24297TG2013PLC087048, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
U24297TG2013PLC087048 Current
U24297AP2013PLC087048 Previous

Business Activity of Eugia Pharma Specialities Limited

Eugia Pharma Specialities Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Business activity turnover details for Eugia Pharma Specialities Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Eugia Pharma Specialities Limited

Eugia Pharma Specialities Limited is audited by Walker Chandiok & Co LLP for the financial year 2024. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
Walker Chandiok & Co LLP Locked Locked Locked
Premium access

Complete auditor history for Eugia Pharma Specialities Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors and KMP of Eugia Pharma Specialities Limited

Eugia Pharma Specialities Limited currently reports 5 directors and 1 key managerial person. 24 former directors have served the organization.

Current Directors and KMP
Name Designation Appointment Date Tenure Status
Madan Mohan Reddy Mettu Director 17 Apr 2013 13 Years 2 Months Current
Veerayya Chowdary Kosaraju Director 01 Dec 2021 4 Years 7 Months Current
Yugandhar Puvvala Ceo 01 Oct 2021 4 Years 9 Months Current
Santhanam Subramanian Director 01 Oct 2021 4 Years 9 Months Current
Ragunathan Kannan Director 01 Dec 2021 4 Years 7 Months Current
Sundari Raviprasad Pisupati Director 01 Dec 2021 4 Years 7 Months Current

Financials of Eugia Pharma Specialities Limited FY 2025 filings available

Eugia Pharma Specialities Limited reported revenue of ₹4,828.71 Cr (up 12.00% YoY) for FY 2025.

Revenue · FY 2025
₹4,828.71 Cr ▲ 12.00%
Premium access

Ten-year financial statements for Eugia Pharma Specialities Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Eugia Pharma Specialities Limited

Premium access

Shareholding and ownership data for Eugia Pharma Specialities Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Group Structure of Eugia Pharma Specialities Limited

Eugia Pharma Specialities Limited has 2 subsidiary companies. This group structure data is as of FY 2024. The corporate group structure reflects Eugia Pharma Specialities Limited's business expansion strategy and organizational complexity.

2
Subsidiary companies
Key Subsidiaries
Company Name CIN Shares Held
Eugia Steriles Private Limited U24239TG2020PTC141428 Locked
Eugia Sez Private Limited U24299TG2021PTC148856 Locked

Showing major subsidiaries. Total: 2.

Charges & Borrowings of Eugia Pharma Specialities Limited

Open charges
₹0
Satisfied charges
₹724 Cr
Breakdown by lending institutions
Others₹605.00 Cr
Export Import Bank of India₹119.00 Cr
Latest charge details
DateLenderAmountStatus
27 Sep 2019 Others ₹105 Cr Satisfied
06 Jul 2017 Others ₹500 Cr Satisfied
24 Feb 2014 Export Import Bank of India ₹119 Cr Satisfied

Total charge records: 3 View all charges

Employees and EPFO Compliance at Eugia Pharma Specialities Limited

Eugia Pharma Specialities Limited has a workforce of 2,763 employees as of Feb 14, 2025.

Employee count
2,763
Active EPFO establishments
2
Employee growth
10.26%
Premium access

Employee and EPFO history for Eugia Pharma Specialities Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Eugia Pharma Specialities Limited

Premium access

GST registrations and filing compliance for Eugia Pharma Specialities Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Eugia Pharma Specialities Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Eugia Pharma Specialities Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Eugia Pharma Specialities Limited

Premium access

MSME payment history for Eugia Pharma Specialities Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Eugia Pharma Specialities Limited

Premium access

Corporate group structure for Eugia Pharma Specialities Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Eugia Pharma Specialities Limited

Premium access

MCA filings and documents for Eugia Pharma Specialities Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Eugia Pharma Specialities Limited

Activity
08 Sep 2025
Eugia Pharma Specialities Limited last Annual general meeting of members was held on 08 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
Eugia Pharma Specialities Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Directors
21 Feb 2024
Vallamkondu Aravind Kumar was appointed as a Cfo on 21 Feb 2024 & has been associated with this company since 2 years 4 months.
Charges
04 Mar 2022
A charge registered on 27 Sep 2019 via Charge ID 100295568 with Others was fully satisfied on 04 Mar 2022.
Directors
27 Dec 2021
Yugandhar Puvvala was appointed as a CEO on 27 Dec 2021 & has been associated with this company since 4 years 6 months.
Directors
01 Dec 2021
Veerayya Chowdary Kosaraju was appointed as a Director on 01 Dec 2021 & has been associated with this company since 4 years 7 months.

Recent News on Eugia Pharma Specialities Limited

Frequently Asked Questions about Eugia Pharma Specialities Limited

Eugia Pharma Specialities Limited is an active public limited company in the pharma sector based in Ameerpet, Telangana, India. It was incorporated on 17 April 2013 (13+ years old) and is registered under CIN U24297TG2013PLC087048. The company has 2,763 employees.

Eugia Pharma Specialities Limited reported revenue of ₹4,828.71 Cr for FY 2025 (up 12.00% YoY).

The current directors and KMP of Eugia Pharma Specialities Limited are:

The primary industry of Eugia Pharma Specialities Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Eugia Pharma Specialities Limited can be reached at the registered office: Plot No.2 Maitrivihar, Ameerpet, Telangana, India – 500038, or through the website eugiapharma.com.

The authorised capital is ₹800 Cr, and the paid-up capital is ₹621.01 Cr.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available